Ignite Creation Date:
2024-05-06 @ 3:51 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04786262
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2021-03-03
Brief Title:
A Safety Tolerability and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Vertex Pharmaceuticals Incorporated
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-02
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-03
First Submit QC Date:
March 3 2021
Study First Post Date:
2021-03-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-09
Last Update Post Date:
2024-06-07
Last Update Post Date Type:
ACTUAL